Improving diagnosis and treatment for rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial is looking at how to improve the diagnosis and treatment of rectal cancer by reviewing MRI scans and reports. It may help doctors make better treatment decisions for people with this type of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed rectal cancer (from a biopsy or surgery).
- Your hospital can share your MRI scans, pathology reports, and imaging reports for review.
- You are 16 years old or older.
- Your cancer is not too far advanced to be removed with surgery (no unresectable spread).
- You are not receiving only palliative care (treatment aimed at comfort, not cure).
- Your rectal cancer must be adenocarcinoma (a common type) – not another rare type.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
This trial tests whether doing daily MRI scans during planned radiotherapy can help guide treatment. It may benefit people by improving how accurately the team sees the target area each day.
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
Hear when a new GI Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.